Rankings
▼
Calendar
CERS Q4 2024 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena
CERS
Cerus Corporation
$358M
Q4 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$51M
+8.6% YoY
Gross Profit
$27M
53.9% margin
Operating Income
-$1M
-2.9% margin
Net Income
-$3M
-5.0% margin
EPS (Diluted)
$-0.01
QoQ Revenue Growth
+10.4%
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
$4M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$201M
Total Liabilities
$144M
Stockholders' Equity
$56M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$51M
$47M
+8.6%
Gross Profit
$27M
$26M
+5.5%
Operating Income
-$1M
$976,000
-248.5%
Net Income
-$3M
-$1M
-89.8%
Revenue Segments
Product
$51M
90%
Government Contract
$6M
10%
← FY 2024
All Quarters
Q1 2025 →